Willemina R.R. Geurts-Giele
Papers
1
Total Citations
86
H-Index
1
About
Dr. Willemina R.R. Geurts-Giele is a leading molecular pathologist whose work is reshaping cancer diagnostics through the power of whole genome sequencing (WGS). Her primary research focuses on the clinical implementation and validation of comprehensive genomic profiling for oncology, aiming to replace fragmented, multi-test workflows with a single, all-inclusive assay. Her landmark 2021 study, which has garnered 86 citations, clinically validated the use of WGS on fresh-frozen tumor tissue and matched blood samples, demonstrating its feasibility as the most complete genetic tumor test. This work directly addresses the modern challenge of small biopsy samples and the growing number of biomarkers required for precision medicine. By proving that a single WGS test can capture all relevant genomic alterations, Dr. Geurts-Giele is paving the way for more efficient, cost-effective, and comprehensive cancer care. Her contributions are instrumental in moving the field from targeted panels toward a truly holistic genomic view of each patient’s disease, promising to accelerate the delivery of personalized therapies.
Research Focus
Key Achievements
Top Papers
- 1Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics86 citations · 2021